We have, for the first time, demonstrated altered arrestin isoform expression in the resistance arteries of SHRs that is responsible for driving the enhanced desensitization of vasoconstrictor-mediated PLC signaling observed in hypertension. Here, HSPG2 is linked to hypertensive disorder.